Business Context and Reporting Period
EUDA Health Holdings Limited, a foreign private issuer, filed Form 6-K for February 2024. The filing reports an amendment dated February 29, 2024, to a convertible promissory note issued in connection with the November 2022 business combination with 8i Acquisition 2 Corp.
Key Financial Terms
- Note principal: $2,113,125.
- Interest: The note bears no interest.
- Original conversion price: $5.00 per ordinary share, at the holder’s option.
- Amended maturity date: July 31, 2024, extended from November 17, 2023.
- Amended mandatory conversion: Any amounts outstanding on July 31, 2024 will automatically convert into ordinary shares at $1.50 per share.
The filing does not provide revenue, profit, cash flow, margin, balance-sheet liquidity, or broader debt metrics for the reporting period.
Material Changes
- Maxim Group LLC, the holder, agreed not to exercise the note’s voluntary conversion provision.
- The maturity date was extended by approximately eight months from November 17, 2023 to July 31, 2024.
- The conversion price applicable to amounts outstanding at maturity was set at $1.50 per share, compared with the prior fixed voluntary conversion price of $5.00 per share.
Outlook, Risks, and Unusual Items
- If the note remains unpaid at maturity, the company would be required to issue ordinary shares through automatic conversion, resulting in equity dilution. Based solely on the stated principal, conversion at $1.50 would imply approximately 1,408,750 shares, before considering any other amounts due or applicable terms.
- The filing does not state whether the note was repaid, refinanced, or converted by the filing date.
- The lower maturity conversion price may increase potential dilution relative to the original $5.00 conversion price.
- No management guidance, operating outlook, contingencies beyond the note amendment, or other unusual items are disclosed.
Investor Verification Priorities
- Verify the note’s outstanding balance and whether any amounts other than principal are subject to automatic conversion.
- Confirm the number of ordinary shares issuable upon conversion and the resulting ownership dilution.
- Check subsequent filings for repayment, conversion, further amendments, or default after July 31, 2024.
- Review the attached Note Amendment No. 1 for the complete conversion and maturity provisions.